8 results
8-K/A
EX-99.1
TXMD
TherapeuticsMD Inc
16 Nov 21
Results of Operations and Financial Condition
6:30am
outside the previously approved specification.
To be clear, this submission and potential approval by the FDA would have no impact on our product … quality. We foresee a Q4 pathway that would permit satisfying increasing patient demand. But this is the first time that our ability to adequately meet
8-K
EX-4.1
rckss0m v4b4ixe5
2 Oct 12
Therapeuticsmd, Inc. Announces $8.5 Million Private Placement
12:00am
- Prev
- 1
- Next